XILONG SCIENTIFIC(002584)

Search documents
西陇科学:内部控制审计报告
2024-04-26 08:41
西陇科学股份有限公司 内部控制审计报告 内部控制审计报告 中兴财光华审专字(2024)第 101003 号 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外,由于 情况的变化可能导致内部控制变得不恰当,或对控制政策和程序遵循的程度降低, 根据内部控制审计结果推测未来内部控制的有效性具有一定风险。 四、财务报告内部控制审计意见 中兴财光华审专字(2024)第101003号 西陇科学股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求, 我们审计了西陇科学股份有限公司(以下简称"西陇科学")2023 年 12 月 31 日 的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业 内部控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效 性是西陇科学董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 审计意见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 我们认为,西陇科学于2023年12月31日按照《企业内部控 ...
西陇科学:监事会决议公告
2024-04-26 08:41
证券代码:002584 证券简称:西陇科学 公告编号:2024-022 西陇科学股份有限公司 第六届监事会第二次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整,没有 虚假记载、误导性陈述或重大遗漏。 西陇科学股份有限公司(以下简称"公司")第六届监事会第二次会议通知 于2024年4月15日以电话、专人送达方式通知公司全体监事。会议于2024年4月25 日以现场方式在公司五楼会议室召开。本次会议应出席监事3人,实际出席监事3 人,公司董事会秘书列席了会议,会议的召集、召开程序符合《公司法》和《公 司章程》的有关规定。会议由监事会主席牛佳先生主持,经与会监事审议并以记 名投票方式表决,通过如下决议: 1、审议通过了《2023 年度监事会工作报告》 表决结果:3 票同意,0 票弃权,0 票反对 《西陇科学:2023 年度监事会工作报告》具体内容刊登于巨潮资讯网。 本议案尚需提交公司 2023 年度股东大会审议。 2、审议通过了《2023 年年度报告及摘要》 表决结果:3 票同意,0 票弃权,0 票反对 经审核,董事会审议公司 2023 年度报告及摘要的程序符合法律、法规和中国 证监会、深圳证 ...
西陇科学(002584) - 2024 Q1 - 季度财报
2024-04-26 08:41
Financial Performance - The company's revenue for Q1 2024 was ¥2,180,464,759.55, representing a 12.52% increase compared to ¥1,937,787,670.11 in the same period last year[5] - Net profit attributable to shareholders decreased by 29.76% to ¥7,046,896.18 from ¥10,032,938.44 year-on-year[5] - Net profit for Q1 2024 was ¥7,263,074.61, a decrease of 29.0% from ¥10,263,465.80 in Q1 2023[16] - Basic earnings per share decreased to ¥0.01 from ¥0.02, reflecting a decline of 50.0% year-over-year[17] Cash Flow - The net cash flow from operating activities improved significantly, reaching ¥5,042,775.40, a 136.62% increase from a negative cash flow of ¥13,769,371.14 in the previous year[8] - The company reported a net cash flow from operating activities of ¥5,042,775.40, recovering from a negative cash flow of ¥13,769,371.14 in the same quarter last year[18] - The net cash flow from investment activities was -67,167,888.32 CNY, compared to a positive cash flow of 23,118,136.33 CNY in the previous period[19] - The total cash inflow from financing activities was 359,902,261.85 CNY, while the cash outflow was 323,142,497.96 CNY, resulting in a net cash flow of 36,759,763.89 CNY[19] - The company experienced a decrease in cash and cash equivalents of 25,170,676.91 CNY during the quarter[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,676,906,903.31, a decrease of 1.93% from ¥4,769,003,949.47 at the end of the previous year[5] - The company's equity attributable to shareholders decreased by 2.91% to ¥2,279,589,712.61 from ¥2,347,994,128.17[5] - Total liabilities decreased slightly to ¥2,391,027,932.72 from ¥2,414,947,856.79, indicating a reduction of 1.0%[16] - Current liabilities total 2,033,891,339.67 CNY, a decrease from 2,069,737,441.43 CNY[12] Investments and Expenses - Research and development expenses surged by 108.75% to ¥27,256,625.41, up from ¥13,057,237.98 in the prior year, indicating increased investment in innovation[8] - Research and development expenses increased significantly to ¥27,256,625.41, compared to ¥13,057,237.98 in the previous year, marking a rise of 108.5%[15] - The company made a new investment of ¥235,805,220.42 in long-term equity, reflecting a 35.17% increase from the previous period[7] - The company experienced a significant increase in tax expenses, which rose to ¥1,657,998.89 from ¥518,340.05, an increase of 220.5%[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 102,133[10] - The largest shareholder, Huang Shaoqun, holds 12.73% of shares, amounting to 74,500,000 shares, with 20,500,000 shares pledged and 7,760,000 shares frozen[10] Other Information - The company has not reported any significant new strategies or product developments in the current quarter[11] - The report was issued by the legal representative Huang Shaoqun on April 25, 2024[20]
西陇科学:年度关联方资金占用专项审计报告
2024-04-26 08:41
西陇科学股份有限公司 2023 年度非经营性资金占用及 其他关联资金往来情况的专项说明 1 关于西陇科学股份有限公司 2023 年度非经营性资金占用及 其他关联资金往来情况的专项说明 中兴财光华审专字(2024)第 101004 号 目 录 关于西陇科学股份有限公司 2023 年度非经营性 资金占用及其他关联资金往来情况的专项说明 西陇科学股份有限公司 2023 年度非经营性资金 占用及其他关联资金往来情况汇总表 西陇科学股份有限公司 2023 年度非经营性资金占用及其他关联资金往来情 况汇总表 (此页无正文) 中兴财光华会计师事务所 中国注册会计师: (特殊普通合伙) 中兴财光华审专字(2024)第 101004 号 西陇科学股份有限公司全体股东: 我们接受西陇科学股份有限公司(以下简称"西陇科学")委托,根据中国 注册会计师执业准则审计了西陇科学 2023 年 12 月 31 日的合并及公司资产负债 表,2023 年度合并及公司利润表、合并及公司现金流量表、合并及公司股东权益 变动表和财务报表附注,并出具了中兴财光华审会字(2024)第 101005 号无保留 意见审计报告。 根据《上市公司监管指引第 8 ...
西陇科学:关于2024年开展套期保值业务的公告
2024-04-26 08:41
证券代码:002584 证券简称:西陇科学 公告编号:2024-033 西陇科学股份有限公司 关于2024年开展套期保值业务的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1、西陇科学股份有限公司(以下简称"公司")及子公司开展套期保值业务主要是 为了规避原材料价格和汇率波动给公司经营带来的不利影响,交易品种仅限与生产经 营相关的产品、原材料以及与贸易业务相关的外汇,其中商品期货、期权套期保值交 易主要在国内期货交易所进行,外汇套期保值交易主要通过有关政府部门批准、具有 相关业务经营资质的银行等金融机构进行。 2、任一时点商品期货及期权套期保值业务保证金和权利金最高余额不超过人民 币 5000万元(不含期货标的实物交割款项),任一交易日持有商品期货及期权套期保 值最高合约价值不超过人民币50,000万元;公司及下属子公司使用不超过2000万美元 1 险,公司及控股子公司拟根据生产经营计划择机开展商品期货期权套期保值业务,保 证产品成本的相对稳定,降低价格波动对生产经营的影响。 (含本数)或等值人民币的自有资金开展外汇套期保值交易,在开展 ...
西陇科学:董事会审计委员会对会计师事务所2023年度履职情况评估及履行监督职责情况的报告
2024-04-26 08:41
西陇科学股份有限公司 审计委员会对 2023 年度会计师事务所履职情况评估 一、2023 年年审会计师事务所基本情况 (一)会计师事务所基本情况 中兴财光华长期从事证券服务业务,于 2013 年转制为特殊普通合伙,首席 合伙人为姚庚春先生,管理总部设立于北京,并在全国各地设立了 35 家分所。 中兴财光华一直以来注重人才培养,具有从事上市公司审计工作的丰富经验和职 业素养,截至 2023 年 12 月 31 日有合伙人 183 人、注册会计师 823 人。 中兴财光华主要从事上市公司审计、IPO 审计、发债审计、新三板年报审计 及其他特定目的审计,服务的客户遍及电信、金融、保险、证券、石化、石油、 钢铁、有色金属、陶瓷、外贸、纺织、物产、电力、电子、电气、新闻出版、科 技、交通运输、冶金、机械制造、制药、农牧业、房地产等领域。 中兴财光华 2022 年度业务收入 10.09 亿元,其中审计业务收入 8.84 亿元; 2022 年度上市公司年报审计客户 92 家。 (二)聘任会计师事务所履行的程序 公司于 2023 年 10 月 27 日召开的第五届董事会第二十四次会议审议通过了 《关于续聘会计师事务所的议案》 ...
西陇科学(002584) - 2023 Q4 - 年度财报
2024-04-26 08:41
Financial Performance - The company's operating revenue for 2023 was ¥7,693,246,557.87, representing a 24.42% increase compared to ¥6,183,208,812.19 in 2022[18]. - The net profit attributable to shareholders decreased by 62.56% to ¥33,347,824.31 in 2023 from ¥88,047,360.97 in 2022[18]. - The net profit after deducting non-recurring gains and losses increased by 228.91% to ¥28,764,969.00 in 2023 from ¥7,608,961.07 in 2022[18]. - Basic earnings per share decreased by 60.00% to ¥0.06 in 2023 from ¥0.15 in 2022[18]. - The total revenue for the reporting period reached ¥7,693,246,557.87, representing a year-on-year increase of 24.42% compared to ¥6,183,208,812.19 in 2022[56]. - The chemical industry accounted for 99.61% of total revenue, with a revenue of ¥7,662,983,480.62, reflecting a 25.15% increase from the previous year[56]. - The revenue from electronic chemicals was ¥988,534,573.93, accounting for 12.85% of total revenue, with a year-on-year growth of 16.75%[56]. - The specialized chemicals segment saw a significant increase of 180.00%, with revenue reaching ¥2,544,130,304.55 in 2023, compared to ¥909,526,770.41 in 2022[64]. - The general reagents segment experienced a decline of 12.00%, with revenue falling to ¥714,720,334.79 in 2023 from ¥811,644,135.31 in 2022[64]. - The revenue from lithium battery cathode materials decreased by 23.00%, amounting to ¥23,156,255.11 in 2023, down from ¥29,946,252.01 in 2022[64]. Cash Flow and Assets - The cash flow from operating activities showed a negative net amount of ¥284,714,593.53, worsening by 49.16% compared to the previous year's negative cash flow of ¥190,882,683.70[18]. - The company's cash and cash equivalents decreased to ¥559,890,014.28 at the end of 2023, down from ¥691,010,308.36 at the beginning of the year, a decline of 2.14%[80]. - Accounts receivable increased to ¥1,392,659,790.97, representing 29.20% of total assets, up from 23.24% in the previous year[80]. - Fixed assets rose to ¥622,556,581.22, accounting for 13.05% of total assets, an increase of 3.28% from the previous year[80]. - The total assets at the end of 2023 were ¥4,769,003,949.47, a decrease of 4.23% from ¥4,977,416,163.23 at the end of 2022[19]. Dividends and Shareholder Returns - The company plans to distribute a cash dividend of 0.2 RMB per 10 shares to all shareholders, based on a total of 585,216,422 shares[4]. - The company reported a cash dividend of 11,704,328.44 CNY, which represents 100% of the total profit distribution amount[152]. - The company has a total of 839,226,760.66 CNY in distributable profits available for distribution[152]. - The company did not distribute cash dividends for the 2022 fiscal year, despite having positive distributable profits[151]. Research and Development - The company has established a long-term cooperative relationship with several well-known domestic universities and research institutes, holding 97 authorized patents[39]. - The company applied for 13 patents and received 14 patent authorizations during the reporting period, highlighting its commitment to innovation[52]. - Research and development expenses increased by 5.79% to ¥95,701,006.19 in 2023, up from ¥90,467,409.76 in 2022[69]. - R&D investment amounted to ¥134,412,916.02 in 2023, an increase of 4.41% from ¥128,735,270.36 in 2022[74]. - The number of R&D personnel decreased by 10.11% from 188 in 2022 to 169 in 2023, with a slight drop in the proportion of R&D personnel from 14.83% to 14.58%[73]. Operational Risks and Challenges - The company faces risks including macroeconomic downturns, safety production risks, environmental risks, technology research and development risks, and management risks[4]. - The company has indicated uncertainty regarding its ability to continue as a going concern, as the net profit before non-recurring items has been negative for the last three accounting years[20]. - The management team faces challenges due to the complexity of the organizational structure and management system resulting from strategic transformation[107]. - The company has identified risks related to macroeconomic downturns, which could impact profit margins and inventory levels[102]. Environmental and Safety Management - The company is committed to environmental protection, adjusting its product structure to comply with stricter environmental standards[105]. - All pollution discharge from the company's production facilities is 100% compliant with national and local environmental regulations, with all projects passing environmental impact assessments[167]. - The company has established a comprehensive waste management strategy, focusing on recycling and proper disposal of hazardous materials[177]. - The company has achieved a solid waste disposal safety rate of 100% for hazardous waste, ensuring compliance with regulations[177]. - The company has made commitments regarding stock transfer limits, ensuring that no more than 25% of their holdings will be sold within a specified timeframe[199]. Corporate Governance - The company maintains a complete and independent corporate governance structure, including a board of directors and supervisory board[120]. - The company has established a robust investor relations management system to enhance communication and build trust with investors[118]. - The board of directors has convened 5 meetings during the reporting period, demonstrating diligence and compliance with governance standards[113]. - The company has established an independent financial accounting system and decision-making process, ensuring no interference from shareholders in fund usage[120]. Employee Management and Training - The company has implemented a comprehensive training program to enhance employee skills and professional development[150]. - The total number of employees at the end of the reporting period is 1,159, with 483 in the parent company and 676 in major subsidiaries[147]. - The company has a diverse employee training system targeting new employees, professionals, and management personnel[150]. - The company has implemented a flexible compensation management system to motivate employees and has provided various welfare benefits, including annual health check-ups[187]. Market Position and Strategy - The company is focusing on expanding its market presence in the new energy and semiconductor materials sectors[101]. - The company is actively pursuing mergers and acquisitions to strengthen its market position and expand its product offerings[101]. - The company anticipates a market growth in electronic chemicals, with the market size expected to reach 6.13 billion by 2023, representing an 8.3% year-on-year increase[98]. - The company aims to leverage its competitive advantages in technology R&D and brand recognition to enhance market penetration[101].
西陇科学:独立董事年度述职报告
2024-04-26 08:41
公司全体股东、股东代表: 独立董事 2023 年度述职报告 西陇科学股份有限公司 独立董事 2023 年度述职报告(吴守富) 作为西陇科学股份有限公司(以下简称"公司")的独立董事,本人以维护 公司、股东和投资者的利益为原则,根据《公司法》《上市公司独立董事管理办 法》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》 《公司章程》《公司独立董事工作制度》及有关法律、法规的规定和要求,谨慎、 认真、勤勉地行使公司所赋予独立董事的权利和职责。现将本人 2023 年度履职 情况汇报如下: 一、独立董事基本情况 (一)工作履历情况 吴守富,1967 年出生,中国国籍,无境外永久居留权,毕业于安徽财贸学院 会计学专业,于上海财经大学完成金融投资与管理研修;高级会计师、注册会计 师、注册资产评估师、注册税务师,具有法律职业资格。现为上海通展会计师事 务所合伙人,曾于安徽华普会计师事务所担任高级审计经理、于安徽吉顺交通工 业有限公司担任财务总监、于上海天智资产管理有限公司担任财务总监、于安徽 飞彩(集团)有限公司及安徽飞彩车辆股份有限公司担任财务经理、会计科长、 第二届监事会监事。现任公司独立董事。 ...
西陇科学:关于2023年度计提资产减值准备及核销资产的公告
2024-04-26 08:38
证券代码:002584 证券简称:西陇科学 公告编号: 2023-027 西陇科学股份有限公司 关于 2023 年度计提资产减值准备及核销资产的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或者重大遗漏。 西陇科学股份有限公司(以下简称"公司")于2024年4月25日召开第六届董事会第 二次会议、第六届监事会第二次会议,会议审议通过了公司《关于2023年度计提资产减值 准备及核销资产的议案》。现将具体内容公告如下: 一、本次计提资产减值准备及核销资产情况概述 (一)本次计提资产减值准备及核销资产的原因 根据《企业会计准则》、《深圳证券交易所上市公司规范运作指引》的相关规定,为 了真实、准确地反映公司截至2023年12月31日的资产状况和财务状况,本着谨慎性原则 ,公司及下属子公司对资产进行了清查并进行了充分的分析和评估,对可能发生减值损 失的资产计提减值准备并对部分资产进行核销。 (二)本次减值准备计提情况 公司本次计提减值准备的资产项目为2023年末应收票据、应收账款、其他应收款 、存货等资产,2023年度计提减值准备4,637.17万元,转回减值准备2,104. ...
西陇科学:2023年度非经营性资金占用及其他关联资金往来情况汇总表
2024-04-26 08:38
西陇科学股份有限公司 2023年度非经营性资金占用及其他关联资金往来情况汇总表 法定代表人: 主管会计工作负责人: 会计机构负责人: 1 | 编制单位:西陇科学股份有限公司 | | | | | | | | | 单位:万元 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公 | 上市公司核算 | 2023年期初占用资金余 | 2023年度占用累计发 | 2023年度占用 资金的利息 | 2023年度偿还 | 2023年期末占用 占用形成原因 | 占用性质 | | | | 司的关联关系 | 的会计科目 | 额 | 生金额(不含利息) | (如有) | 累计发生金额 | 资金余额 | | | 控股股东、实际控制 | | | | | | | | | | | 人及其附属企业 | | | | | | | | | | | 小计 | | | | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | | 前控股股东、实际控 | | | | | | | | | | | 制人 ...